Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias

Completed

Conditions studied: Cardiac Arrhythmias, Electroanatomic Mapping, Cardiac Ablation

In brief

The purpose of this study is to compare two different types of three-dimensional electroanatomic mapping systems used for the treatment of cardiac arrhythmias. The systems will be compared in regards to its ability to successfully map and ablate a clinical arrhythmia, as well as the time invested in this activity.

Key facts

Study ID

NCT03094221

Run by

Beth Israel Deaconess Medical Center

People needed

20

Starts

2015-01-13

Expected to finish

2015-12-01

Last updated by the study team

2017-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients above the age of 18 years old.
• Patients with the diagnosis of atrial or ventricular arrhythmias presenting for electrophysiology study.
• Patients must be able to understand and critically review the informed consent form.

You may not qualify if…

• Patients whom are unable to provide informed consent.
• Patients with ventricular hypertrophy (LV septum thickness ≥15mm).
• Patients with prosthetic or stenotic cardiac valves present in the chamber where endocardial mapping is planned
• Patients with active systemic infections
• Patients that are pregnant or lactating.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.